Si un de vos proches décède à l’hôpital, il sera transféré après quelques heures à la chapelle mortuaire du CHUV. Les visites y sont possibles aux horaires indiqués ci-contre. Pour que nous puissions vous accueillir au mieux, nous vous conseillons d’appeler avant votre visite. Une place de parc est
Le Centre de chirurgie ambulatoire du CHUV est un bâtiment réservé aux interventions chirurgicales ambulatoires. Veuillez noter qu’il n’y a pas assez d’espace pour que vos proches puissent vous attendre sur place pendant toute la durée de votre intervention. Des cafétérias et autres lieux publics so
Le Bâtiment hospitalier principal, souvent abrégé BH, abrite la plupart des chambres de patient-es du CHUV, ainsi que diverses consultations spécialisées. Au niveau de l’entrée principale (BH08), vous trouvez des offres générales destinées aux patient-es: l’Accueil général, le Bureau des admissions,
We build explainable AI methods that uncover the biological and spatial drivers behind AI model predictions, enabling discovery of biological mechanisms, and spatial biomarkers that can be pursued for validation and therapeutic targeting. In the Interpret theme, we develop AI methods that provide ex
We develop models that learn unified, multimodal representations of biological systems, integrating diverse data types — from single-cell and spatial omics to histopathology imaging — so that heterogeneous cellular states, tissue morphology and spatial architecture are jointly captured. In the Repre
We have developed Meditron-CHUV, an open-source medical Large Language Model, fine-tuned on more than 12,000 clinician preference annotations from over 250 CHUV clinicians. We introduce a clinician-centric framework that positions human expert participation as a central pillar of LLM development and
This project aims to develop a comprehensive prediction model for chronic kidney disease by integrating classical risk factors with inherited and acquired genetic data. To do so we will use the cutting-edge Blended Genome–Exome sequencing technology on DNA samples from the Swiss HIV Cohort Study, as
We develop multilingual natural language processing tools to securely analyze and summarize clinical notes, improve pharmacovigilance, and enhance patient understanding of medical information. For this project, funded by the Swiss National Science Foundation, we are developing advanced tools using a
An international project aiming to establish the role of germline DNA variation in determining the efficacy and toxicity of cancer immunotherapy. We analyze the DNA of patients undergoing immunotherapy to identify biomarkers that can help predict the efficacy and toxicity of these treatments. An imp